Process View
The chemical reactions and pathways resulting in the breakdown of neutral lipids, lipids only soluble in solvents of very low polarity.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "neutral lipid catabolic process"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| CDK2 | cyclin-dependent kinase 2 | 1.000 | Yeast | |
| ALB | albumin | 1.000 | ||
| APOA1 | apolipoprotein A-I | 1.000 | Human | |
| CCNE1 | cyclin E1 | 1.000 | ||
| APOA2 | apolipoprotein A-II | 1.000 | ||
| APOC3 | apolipoprotein C-III | 0.999 | ||
| CCNA2 | cyclin A2 | 0.999 | ||
| CCNB2 | cyclin B2 | 0.998 | ||
| FGA | fibrinogen alpha chain | 0.997 | ||
| HP | haptoglobin | 0.992 | ||
| SKP2 | S-phase kinase-associated protein 2 (p45) | 0.992 | ||
| APOC1 | apolipoprotein C-I | 0.972 | ||
| APOE | apolipoprotein E | 0.948 | ||
| LCAT | lecithin-cholesterol acyltransferase | 0.925 | ||
| UHRF2 | ubiquitin-like with PHD and ring finger domains 2 | 0.876 | ||
| APOB | apolipoprotein B (including Ag(x) antigen) | 0.792 | Mouse | |
| APOC2 | apolipoprotein C-II | 0.786 | ||
| AHSG | alpha-2-HS-glycoprotein | 0.731 | ||
| TTR | transthyretin | 0.673 | ||
| CDT1 | chromatin licensing and DNA replication factor 1 | 0.627 | ||
| CDKN1B | cyclin-dependent kinase inhibitor 1B (p27, Kip1) | 0.559 | ||
| ORC1 | origin recognition complex, subunit 1 | 0.493 | ||
| RPL18A | ribosomal protein L18a | 0.440 | ||
| CCNB1 | cyclin B1 | 0.433 | ||
| UBE2R2 | ubiquitin-conjugating enzyme E2R 2 | 0.373 | ||
| TNFRSF10C | tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain | 0.356 | ||
| APOA4 | apolipoprotein A-IV | 0.333 | ||
| CKS1B | CDC28 protein kinase regulatory subunit 1B | 0.299 | ||
| AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 0.287 | ||
| GPLD1 | glycosylphosphatidylinositol specific phospholipase D1 | 0.254 | Mouse | |
| F7 | coagulation factor VII (serum prothrombin conversion accelerator) | 0.200 | ||
| F2 | coagulation factor II (thrombin) | 0.199 | ||
| TXNDC2 | thioredoxin domain containing 2 (spermatozoa) | 0.187 | ||
| MDK | midkine (neurite growth-promoting factor 2) | 0.156 | ||
| CA5A | carbonic anhydrase VA, mitochondrial | 0.150 | ||
| HPX | hemopexin | 0.128 | ||
| BAAT | bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase) | 0.116 | ||
| SLC2A2 | solute carrier family 2 (facilitated glucose transporter), member 2 | 0.114 | ||
| APCS | amyloid P component, serum | 0.098 | ||
| KNG1 | kininogen 1 | 0.096 | ||
| SERPINC1 | serpin peptidase inhibitor, clade C (antithrombin), member 1 | 0.092 | ||
| LIPC | lipase, hepatic | 0.082 | ||
| ALDOB | aldolase B, fructose-bisphosphate | 0.070 | ||
| FGG | fibrinogen gamma chain | 0.068 | ||
| FGB | fibrinogen beta chain | 0.065 | ||
| MTTP | microsomal triglyceride transfer protein | 0.064 | ||
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.063 | ||
| HMGB2 | high mobility group box 2 | 0.061 | ||
| CKS2 | CDC28 protein kinase regulatory subunit 2 | 0.055 | ||
| CCND1 | cyclin D1 | 0.055 | ||
| CPB2 | carboxypeptidase B2 (plasma) | 0.053 | ||
| CDK6 | cyclin-dependent kinase 6 | 0.050 | ||
| HPD | 4-hydroxyphenylpyruvate dioxygenase | 0.048 | ||
| SERPINA6 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 | 0.046 | ||
| AMBP | alpha-1-microglobulin/bikunin precursor | 0.044 | ||
| FAM83C | family with sequence similarity 83, member C | 0.044 | ||
| ARG1 | arginase, liver | 0.040 | ||
| TF | transferrin | 0.040 | ||
| FABP1 | fatty acid binding protein 1, liver | 0.040 | ||
| GBF1 | golgi brefeldin A resistant guanine nucleotide exchange factor 1 | 0.037 | ||
| ADH6 | alcohol dehydrogenase 6 (class V) | 0.037 | ||
| AFP | alpha-fetoprotein | 0.036 | ||
| ITIH1 | inter-alpha (globulin) inhibitor H1 | 0.035 | ||
| AGXT | alanine-glyoxylate aminotransferase | 0.033 | ||
| A2M | alpha-2-macroglobulin | 0.032 | ||
| APOC4 | apolipoprotein C-IV | 0.032 | ||
| PTPN5 | protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched) | 0.031 | ||
| EEF2K | eukaryotic elongation factor-2 kinase | 0.031 | ||
| C4BPB | complement component 4 binding protein, beta | 0.030 | ||
| CFB | complement factor B | 0.030 | ||
| ANGPTL3 | angiopoietin-like 3 | 0.030 | ||
| ZG16 | zymogen granule protein 16 homolog (rat) | 0.029 | ||
| PKMYT1 | protein kinase, membrane associated tyrosine/threonine 1 | 0.028 | ||
| HABP2 | hyaluronan binding protein 2 | 0.028 | ||
| BHMT | betaine--homocysteine S-methyltransferase | 0.027 | ||
| SLC38A3 | solute carrier family 38, member 3 | 0.026 | ||
| PLG | plasminogen | 0.026 | ||
| AKR1C4 | aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4) | 0.024 | ||
| MAT1A | methionine adenosyltransferase I, alpha | 0.023 | ||
| FGL1 | fibrinogen-like 1 | 0.022 | ||
| ASGR2 | asialoglycoprotein receptor 2 | 0.022 | ||
| LIPE | lipase, hormone-sensitive | 0.020 | ||
| RBP4 | retinol binding protein 4, plasma | 0.020 | ||
| CYP4F2 | cytochrome P450, family 4, subfamily F, polypeptide 2 | 0.020 | ||
| ASGR1 | asialoglycoprotein receptor 1 | 0.020 | ||
| AGXT2 | alanine--glyoxylate aminotransferase 2 | 0.020 | ||
| SERPINA10 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10 | 0.019 | ||
| ITIH2 | inter-alpha (globulin) inhibitor H2 | 0.019 | ||
| LBP | lipopolysaccharide binding protein | 0.019 | ||
| CCNA1 | cyclin A1 | 0.019 | ||
| FABP2 | fatty acid binding protein 2, intestinal | 0.019 | ||
| AGT | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) | 0.019 | ||
| ORM2 | orosomucoid 2 | 0.019 | ||
| OTC | ornithine carbamoyltransferase | 0.018 | ||
| SERPINF2 | serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 | 0.018 | ||
| AFM | afamin | 0.018 | ||
| E2F1 | E2F transcription factor 1 | 0.018 | ||
| APOH | apolipoprotein H (beta-2-glycoprotein I) | 0.018 | ||
| KIAA1377 | KIAA1377 | 0.018 | ||
| F11 | coagulation factor XI | 0.017 | ||
| CRP | C-reactive protein, pentraxin-related | 0.017 | ||
| G6PC | glucose-6-phosphatase, catalytic subunit | 0.017 | ||
| VTN | vitronectin | 0.017 | ||
| MASP1 | mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) | 0.017 | ||
| CYP2E1 | cytochrome P450, family 2, subfamily E, polypeptide 1 | 0.017 | ||
| RPS14 | ribosomal protein S14 | 0.016 | ||
| SULT2A1 | sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 | 0.016 | ||
| CLEC4G | C-type lectin domain family 4, member G | 0.016 | ||
| PPP1R9B | protein phosphatase 1, regulatory (inhibitor) subunit 9B | 0.016 | ||
| PAH | phenylalanine hydroxylase | 0.016 | ||
| C4BPA | complement component 4 binding protein, alpha | 0.015 | ||
| SAA4 | serum amyloid A4, constitutive | 0.015 | ||
| SPP2 | secreted phosphoprotein 2, 24kDa | 0.015 | ||
| C8A | complement component 8, alpha polypeptide | 0.015 | ||
| SCARB1 | scavenger receptor class B, member 1 | 0.015 | ||
| HSD17B2 | hydroxysteroid (17-beta) dehydrogenase 2 | 0.014 | ||
| C13orf15 | chromosome 13 open reading frame 15 | 0.014 | ||
| PON1 | paraoxonase 1 | 0.014 | ||
| SNX27 | sorting nexin family member 27 | 0.013 | ||
| PCK1 | phosphoenolpyruvate carboxykinase 1 (soluble) | 0.013 | ||
| RNPEPL1 | arginyl aminopeptidase (aminopeptidase B)-like 1 | 0.013 | ||
| MBL2 | mannose-binding lectin (protein C) 2, soluble | 0.013 | ||
| CP | ceruloplasmin (ferroxidase) | 0.013 | ||
| PON3 | paraoxonase 3 | 0.013 | ||
| HMGCS2 | 3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) | 0.013 | ||
| RIBC2 | RIB43A domain with coiled-coils 2 | 0.013 | ||
| C8B | complement component 8, beta polypeptide | 0.013 | ||
| HAO1 | hydroxyacid oxidase (glycolate oxidase) 1 | 0.013 | ||
| ORM1 | orosomucoid 1 | 0.012 | ||
| GLYAT | glycine-N-acyltransferase | 0.012 | ||
| CHEK2 | CHK2 checkpoint homolog (S. pombe) | 0.012 | ||
| KRT16 | keratin 16 | 0.012 | ||
| FTCD | formiminotransferase cyclodeaminase | 0.012 | ||
| CYP3A7 | cytochrome P450, family 3, subfamily A, polypeptide 7 | 0.012 | ||
| CYP8B1 | cytochrome P450, family 8, subfamily B, polypeptide 1 | 0.012 | ||
| CYP27A1 | cytochrome P450, family 27, subfamily A, polypeptide 1 | 0.012 | ||
| SPEF2 | sperm flagellar 2 | 0.012 | ||
| HAL | histidine ammonia-lyase | 0.011 | ||
| CPN1 | carboxypeptidase N, polypeptide 1 | 0.011 | ||
| GPD1 | glycerol-3-phosphate dehydrogenase 1 (soluble) | 0.011 | ||
| MLXIPL | MLX interacting protein-like | 0.011 | ||
| CPN2 | carboxypeptidase N, polypeptide 2 | 0.011 | ||
| ACSL1 | acyl-CoA synthetase long-chain family member 1 | 0.011 | ||
| GYS2 | glycogen synthase 2 (liver) | 0.011 | ||
| PISD | phosphatidylserine decarboxylase | 0.011 | ||
| SPINK1 | serine peptidase inhibitor, Kazal type 1 | 0.011 | ||
| PPARG | peroxisome proliferator-activated receptor gamma | 0.011 | ||
| SLC1A2 | solute carrier family 1 (glial high affinity glutamate transporter), member 2 | 0.011 | ||
| OR8D2 | olfactory receptor, family 8, subfamily D, member 2 | 0.011 | ||
| PCNA | proliferating cell nuclear antigen | 0.011 | ||
| PKLR | pyruvate kinase, liver and RBC | 0.011 | ||
| PLA2G1B | phospholipase A2, group IB (pancreas) | 0.010 | ||
| OR2T6 | olfactory receptor, family 2, subfamily T, member 6 | 0.010 | ||
| CYP2C8 | cytochrome P450, family 2, subfamily C, polypeptide 8 | 0.010 | ||
| LMTK2 | lemur tyrosine kinase 2 | 0.010 |